Louise Frederika Kooij has sold NAMS and made no open-market buys since Oct 2024

Kooij Louise Frederika is a corporate insider and senior finance executive serving as Chief Accounting Officer (CAO) of NewAmsterdam Pharma Co N.V. (NASDAQ: NAMS), a position in which she oversees the company’s accounting, financial reporting, and related compliance functions.( She has been a key member of NewAmsterdam Pharma’s leadership team during its growth as a clinical-stage biopharmaceutical company and has actively participated in the company’s equity incentive programs.(

As a reporting insider, Kooij has disclosed multiple option exercises and share sales in NewAmsterdam Pharma, including a March 2025 transaction in which she sold 150,000 ordinary shares for approximately $3.06 million following option exercises,( and further transactions in January 2026 in which she exercised 72,428 options at $10.90 per share and sold an equal number of ordinary shares at weighted average prices above $31 per share, while retaining both ordinary shares and vested options in the company.( NewAmsterdam Pharma has disclosed that her employment as Chief Accounting Officer is scheduled to end effective August 31, 2026, pursuant to a separation agreement.( Public filings identify her as an individual insider rather than a corporate entity.(

Written by Perplexity from public sources.